Results 251 to 260 of about 232,090 (299)
Challenges to informed consent for exome sequencing: A best–worst scaling experiment
Rachel Gore Moses +3 more
openalex +2 more sources
The FDA published guidance on assessing pharmacokinetics (PK) in participants with impaired renal function in 2024. The IQ CPLG Organ Impairment Working Group summarized the industry’s perspective on this guidance by highlighting a few key updates in the 2024 guidance, including: (1) the recommendation of using estimated glomerular filtration rate ...
Yan Jin +13 more
wiley +1 more source
Public Preference for Off-Label Use of Drugs for Cancer Treatment and Relative Importance of Associated Adverse Events: A Discrete Choice Experiment and Best-Worst Scaling. [PDF]
Wang K +5 more
europepmc +1 more source
Industrial Sustainability Policies: Systematic Literature Review and Research Directions
ABSTRACT Public policies for industrial sustainability have proliferated in recent years, leading to a significant increase in research on the topic. Nevertheless, these studies remain fragmented, and a holistic, up‐to‐date map of research integrating current knowledge from the definition of the agenda setting and policy design to policy evaluation ...
Nunzia Zecchillo +2 more
wiley +1 more source
Best–worst scaling vs. discrete choice experiments: An empirical comparison using social care data
Dimitris Potoglou +6 more
openalex +2 more sources
ABSTRACT This study examines how three subtypes of narcissism—communal, antagonistic, and collective—relate to sustainability team members' willingness to misreport greenhouse gas (GHG) emissions. Using survey‐based online experiments with experienced professionals from the United States and United Kingdom, we assess whether narcissistic traits predict
Eric N. Johnson, Matthias Sohn
wiley +1 more source
Children’s preferences in urban street design: an image-based best-worst scaling experiment
John Stark +5 more
openalex +1 more source
Exploring Consumer Preferences for Potting Mix Characteristics Using Best-Worst Scaling [PDF]
Jerrod Penn +3 more
openalex +1 more source
Market Perceptions of ESG Reputational Risk in the US Pharmaceutical Industry
ABSTRACT Negative ESG‐related reputational events generate significant corporate risks, particularly within sensitive sectors such as the pharmaceutical industry. Using novel reputational data, this research investigates investor perceptions of the consequences of experienced ESG breaches among US pharmaceutical firms.
Erdinc Akyildirim +3 more
wiley +1 more source

